Europos Sąjunga - švedų - EMA (European Medicines Agency)

biogen netherlands b.v.  - fampridine - multipel skleros - andra nervsystemet droger - fampyra är indicerat för förbättring av vandring hos vuxna patienter med multipel skleros med gångavstånd (utökad disability status scale 4-7).

Europos Sąjunga - švedų - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hydroklorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunsuppressiva - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Europos Sąjunga - švedų - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - multipel skleros - andra nervsystemet droger - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - fampridin - depottablett - 10 mg - fampridin 10 mg aktiv substans

Europos Sąjunga - švedų - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - spesolimab - psoriasis - immunsuppressiva - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

newbury pharmaceuticals ab - fampridin - depottablett - 10 mg - fampridin 10 mg aktiv substans